Intelligence / Healthtech / PMA Approvals / Instylla, INC.
Approvalsdevice change approved (PMA)23 Oct 2026
Instylla, INC.
23 Oct 2026: Device change approved (PMA) · Embrace(TM) Hydrogel Embolic System. Recorded in the openFDA device PMA data.
- Decided
- 23 Oct 2026
- Device
- Embrace(TM) Hydrogel Embolic System
- Specialty
- Cardiovascular
- Type
- Supplement (Panel Track)
- Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Reference
- P250003 S008
- Location
- Bedford, MA
What this signal means
A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.
- Cardiovascular leads with 53 of 120, then Pathology (15).
- 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS
Find the decision makers at Instylla, INC.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.
Across AOS Research
Other records for Instylla, INC. in our registers.
23 OctInstylla, INC.device change approved (PMA) · HealthtechApprovals21 OctInstylla, INC.device change approved (PMA) · HealthtechApprovals
More in Cardiovascular
PMA Approvals
6 NovAbbott Vascular (Idef Technologies INC)device change approved (PMA) · Supera Peripheral Stent SystemApprovals6 NovMedalliance, LLCdevice change approved (PMA) · SELUTION SLR 014 PTCA Drug-Eluting BalloonApprovals5 NovAbbott Medicaldevice change approved (PMA) · UltiSynq Defibrillation lead; SurGrip Suture Sleeve AccessoryApprovals4 NovContego Medical, INC.device change approved (PMA) · Neuroguard IEP® 3-in-1 Carotid Stent, Post-Dilation Balloon System with Integrated Embolic ProtectionApprovals4 NovMedtronic Cardiac Rhythm Disease Managementdevice change approved (PMA) · Cobalt MRI CRT-D (DTPB2D1, DTPB2D4, DTPB2Q1, DTPB2QQ); Cobalt XT MRI CRT-D (DTPA2D1, DTPA2D4, DTPA2Q1, DTPA2QQ); Crome MApprovals4 NovMedtronic Cardiac Rhythm Disease Managementdevice change approved (PMA) · Cobalt MRI ICD (DDPB3D1, DDPB3D4, DVPB3D1, DVPB3D4); Cobalt XT MRI ICD (DDPA2D1, DDPA2D4, DVPA2D1, DVPA2D4); Crome MRI IApprovals
Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.